19th International Leprosy Congress: the Plenary Sessions.
Smith WC. Leprosy review. 2016; 87(4):564-9.
Contact management is an essential component of leprosy control.
Smith WC, Aerts A. Leprosy review. 2015; 86(1):126-7.
A research strategy to develop new tools to prevent leprosy, improve patient care and reduce the consequences of leprosy. Five year leprosy research strategy approved by ILEP Board October 2011.
Smith WC. Leprosy review. 2012; 83(1):6-15.
Corticosteroids for treating nerve damage in leprosy.
Van Veen NH, Nicholls PG, Smith WC, Richardus JH. The Cochrane database of systematic reviews. 2007; (2):CD005491.
Multi-centre, double blind, randomized trial of three steroid regimens in the treatment of type-1 reactions in leprosy.
Rao SP, Sugamaran DS, Richard J, Smith WC. Leprosy review. 2006; 77(1):25-33.
Promoting early detection in leprosy--a literature review to identify proven and potential interventions addressing patient-related delay.
Nicholls PG, Ross L, Smith WC. Leprosy review. 2006; 77(4):298-310.
Factors contributing to delay in diagnosis and start of treatment of leprosy: analysis of help-seeking narratives in northern Bangladesh and in West Bengal, India.
Nicholls PG, Chhina N, Bro AK, Barkataki P, Kumar R, Withington SG, et al.. Leprosy review. 2005; 76(1):35-47.
International Leprosy Congress 2002--lessons learned.
Smith WC. Leprosy review. 2003; 74(1):7-10.
Delay in presentation, an indicator for nerve function status at registration and for treatment outcome--the experience of the Bangladesh Acute Nerve Damage Study cohort.
Nicholls PG, Croft RP, Richardus JH, Withington SG, Smith WC. Leprosy review. 2003; 74(4):349-56.
Nasal carriage of Mycobacterium leprae DNA in healthy individuals in Lega Robi village, Ethiopia.
Beyene D, Aseffa A, Harboe M, Kidane D, Macdonald M, Klatser PR, et al.. Epidemiology and infection. 2003; 131(2):841-8.
Use Ris for EndNote, Mendeley, RefWorks, Zotero and most other reference management software.